Predictive value of the QFR in detecting vulnerable plaques in non-flow limiting lesions: a combined analysis of the PROSPECT and IBIS-4 study by Safi, H et al.
1 
 
Predictive value of the QFR in detecting vulnerable plaques in non-flow limiting lesions: 
a combined analysis of the PROSPECT and IBIS 4 study 
 
Introduction  
Fractional flow reserve (FFR) is the gold standard for assessing the physiologic significance of a 
coronary artery lesion and planning treatment. This modality, which also appears able to provide useful 
prognostic information even in non-flow limiting lesions [1], involves advancement of a pressure wire 
across the lesion and adenosine administration to achieve hyperaemia and thus it comes with additional 
procedure-related risks of adverse events, extended procedure time and increased cost [2]. Quantitative 
flow ratio (QFR), a wire-free, hyperaemia-free method has been recently introduced to overcome these 
limitations and derive FFR from models reconstructed from 3-dimensional quantitative coronary 
angiography (3D-QCA) [3]. Recent clinical studies have supported the potential clinical value of QFR 
showing that it enables not only accurate detection of flow limiting lesions but  also identification of 
patients at risk for cardiovascular events [4–7].  
Cumulative data has shown that imaging-derived variables combined with computationally-derived 
physiology indices enable more accurate detection of lesions that are likely to progress and cause events. 
In the EMERLAD study plaque characteristics and the FFR estimated by computed tomography 
allowed detection of lesions that caused myocardial infarction with a higher accuracy than plaque 
morphology (c-index: 0.789 vs. 0.747; P=0.014) [8]. No study today however has assessed whether 
computationally-derived FFR – using the QFR software – has additive predictive value compared with 




The present study is a post hoc analysis of data obtained from the IBIS 4 (Intergraded Biomarkers 
Imaging Study 4) and the PROSPECT (Providing Regional Observations to Study Predictors of Events 
in the Coronary Tree) clinical studies. The study design of these trials, the definitions and endpoints as 
well as the inclusion and exclusion criteria have been described in detail elsewhere [9, 10]. In summary, 
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the IBIS 4 trial was a prospective multi-modality multicenter study which aimed to investigate the effect 
of aggressive statin therapy on plaque composition and burden in patients admitted with a ST-elevation 
myocardial infraction (STEMI). All included patients (n=103) had successful revascularization and 3-
vessel virtual histology intravascular ultrasound (VH-IVUS) and optical coherence tomography (OCT) 
imaging at baseline and 13-month follow-up. 
The PROSPECT study was a prospective large-scale invasive imaging study that aimed to examine the 
ability of VH-IVUS in detecting vulnerable plaques that will evolve and cause events. The study 
included 697 patients admitted with an acute coronary syndrome that had 3-vessel VH-IVUS imaging 
of the proximal 60-80mm segment and successful percutaneous coronary intervention (PCI) in all the 
flow limiting lesions.  
The patients recruited in the IBIS 4 study were follow-up for a median of 5 years whereas those in the 
PROSPECT trial for 3.4 years. The clinical, angiographic and intravascular imaging data in both studies 
allowed detection of untreated lesions that were assessed by VH-IVUS at baseline and caused 
cardiovascular events (defined as cardiac death, myocardial infarction, or revascularization because of 
progressive or unstable angina). In addition, in the IBIS 4 study lesions that exhibited disease 
progression and a significant stenosis (% diameter stenosis, DS ≥70% on QCA) or an intermediate 
stenosis (70%≥%DS≥50%) associated with recurrent angina or evidence of ischemia during exercise 
test at 13 months follow-up angiography were considered culprit and underwent revascularization. The 
primary endpoint of the study was lesions assessed by VH-IVUS at baseline that either progressed and 
required revascularization on repeat angiography, or they caused cardiac death, myocardial infarction, 
or revascularization because of progressive or unstable angina (MACE). 
In the IBIS 4 study all the lesions associated with MACE had either a thin (TCFA, n=13) or a thick-cap 
fibroatheroma (ThCFA, n=2) phenotype, while in the PROSPECT study 43 of the lesions that were 
studied by VH-IVUS at baseline and caused events had a fibroatheroma phenotype (TCFA, n=25; 
ThCFA, n=18), 7 had a non-fibroatheroma phenotype and 4 were unclassified lesions. [9, 10]. From 
these 43 lesions we analysed only data from the lesions that were included in the PROSPECT 
endothelial shear stress (ESS) sub-study a study that aimed to investigate the prognostic value of ESS 
in predicting events [11]. The PROSPECT ESS sub-study included lesions where matching of VH-
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IVUS and X-ray angiography was feasible and had a length ≥9mm and a vulnerable phenotype (TCFA, 
ThCFA). In addition, we included a control group of lesions with a vulnerable phenotype that remained 
quiescent from: 1) the PROSPECT ESS sub-study and from 2) the patients recruited in the IBIS 4 study 
in Bern University Hospital. Lesions with suboptimal angiographic images (for instance vessel 
overlapping or foreshortening or poor opacification of the lumen silhouette) and cases where the 
DICOM file did not include all the required information for QFR analysis were excluded from the study.  
VH-IVUS analysis  
 VH-IVUS analysis was carried out by independent core-laboratories (Cardialysis B.V., Rotterdam, The 
Netherlands in IBIS 4 and Cardiovascular Research Foundation, New York, NY in PROSPECT) using 
dedicated software (QIvus, Medis, Leiden, The Netherlands for the IBIS 4 study and QCU-CMS, 
Medis, Leiden, the Netherlands for the PROSPECT study). In the IBIS 4 trial analysis was performed 
only for the segment that was evaluated by VH-IVUS at baseline and follow-up whereas in the 
PROSPECT trial the analysis was carried out for the entire imaged coronary artery. 
VH-IVUS segmentation was carried out in every end-diastolic frame; in each frame the lumen and 
external elastic membrane (EEM) area were annotated and their dimensions the plaque area and burden 
(PB) and its composition (fibrotic, fibrofatty, calcific and necrotic core area and burden) were estimated. 
In the studied segments lesions were characterised as ≥3 consecutive VH-IVUS frames with PB ≥40%; 
in each lesion the plaque composition was used to classify it to one of the following phenotypes: 
pathologic intimal thickening, fibrotic, fibrocalcific, TCFA and ThCFA.[12]. 
2.3. 3D-QCA reconstruction  
Anatomical landmarks such as side branches observed in X-ray angiography and VH-IVUS were 
utilised to determine the distal and proximal end of the segment that was evaluated by VH-IVUS on 
coronary angiography. Two end-diastolic angiographic projections that were more than 25o apart, where 
there was no foreshortening or overlapping of the segment of interest, that permitted accurate 
delineation of the lumen silhouette were chosen to reconstruct its anatomy utilising an established and 
well-validated software (QAngio XA 3D RE, Medis, Leiden, the Netherlands) [13]. In the obtained 




1.4. QFR analysis 
 
QFR was computed using the Medis Suite XA/QAngio XA 3D/QFR software (Medis, Leiden, the 
Netherlands). QFR was computed using two approaches: 1) assuming a fixed blood flow (fQFR) and 
2) taking into account the flow velocity estimated by the time needed for the contrast agent to fill the 
segment of interest which is known as contrast-flow QFR (cQFR)  [3].  
1.5. Statistical Methods  
Numerical variables are presented as median and interquartile range while categorical variables as 
absolute values and percentages. Comparison between numerical variables were performed using the 
Mann-Whitney U test while categorical variables were compared using the chi-square test. Cox 
regression analysis was used to identify VH-IVUS, 3D-QCA-derived and QFR predictors associated 
with MACE. For the 3D-QCA and QFR variables associated with MACE (P<0.05) receiver-operating 
characteristics curve analysis was performed to identify the best cut-off that predicted MACE. The 
variables with the highest area under the curve (AUC) that were not co-linear (r>0.5) were entered into 
a mulitvariable model to identify independent predictors of MACE.  
VH-IVUS and QFR variables were used to classify the lesions in groups. Kaplan-Meier plots were used 
to display time to event; comparison of MACE rate between groups with different plaque characteristics 
and QFR values was performed using the log-rank test. Analyses were performed in Stata (version 15.1, 
StataCorp LP, College Station, TX) and SPSS (version 23; IBM Corp, Armonk, NY, USA). A P-value 




3.1. Patient demographics 
QFR analysis was possible in 17 MACE lesions with a thin or thick cap fibroatheroma phenotype (5 
from the PROSPECT ESS and 12 from the IBIS 4 study); (Figure 1). From the 122 lesions that were 
included in the PROSPECT ESS study and did not cause events, 8 were excluded from the present 
analysis because of suboptimal angiographic views and 102 were excluded because of insufficient 
information in the DICOM file for QFR analysis. From the 78 thin or thick cap fibroatheromas that 
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were recruited in the IBIS 4 study from Bern University Hospital, 12 lesions were excluded from the 
present analysis because of suboptimal angiographic views.  Therefore the final analysis included 17 
MACE-lesions and a control group of 78 lesions that remained quiescent.   
The baseline characteristics of the patients (n=60) included in the present analysis are shown in Table 
1. There were no differences in the baseline demographics between patients who had an MACE and 
those that did not have an event. 
3.2. Lesions characteristics 
Table 2 shows the morphological and angiographic variables as well as the QFR values in the studied 
lesions. All the studied lesions were non-flow limiting by QFR (range: 0.81-1.00).  
MACE lesions had a smaller MLA and greater PB on VH-IVUS comparing to non-MACE lesions. On 
3D-QCA analysis MACE lesions were longer than the non-MACE lesions and had increased %DS but 
there were no differences in the MLD between groups. Both cQFR and fQFR were lower in the lesions 
that caused MACE.  
3.3. Predictors of MACE lesions  
Two VH-IVUS-derived variables (MLA and PB), two 3D-QCA-derived variables (lesion length, and 
MLD) and the fQFR and cQFR indices were predictors of MACE lesions in univariate analysis (Table 
3). In ROC curve analysis PB (AUC: 0.751, P=0.001), MLA (AUC: 0.734, P=0.003) and cQFR (cutoff 
0.97; AUC: 0.733, P=0.003) were the three variables that had the highest AUC for predicting MACE 
(AUC for fQFR: 0.716, P=0.005). In the multivariable analysis that included cQFR and the presence of 
lesions with PB>70% and small MLA<4.0mm2, a small cQFR (<0.97) was independently associated 
with future events (HR: 3.53, 95%CI: 1.16-10.75; P=0.027); in this model the presence of lesions with 
increased plaque burden and small MLA was not an independent predictor of MACE (HR: 1.87, 95%CI: 
0.64-5.43; P=0.252; Figure 2). 
Lesions were classified in 4 groups according to the presence of ≥2 out of the 3 high-risk plaque 
characteristics that in the PROSPECT study were associated with MACE (MLA ≤4mm2plaque burden 
≥70%, TCFA phenotype) and the cQFR value (<0.97). Lesions with high-risk plaque characteristics 
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and low cQFR had worse prognosis than the other lesions. Similar results were obtained when a high-
risk plaque phenotype was defined as the presence of MLA ≤4 mm2 and PB ≥70% (Figure 3A, 3B).   
 
3. Discussion  
In this study for the first time we examined the value of the computationally derived FFR estimated 
from QFR software in identifying those non-flow limiting lesions with a vulnerable-lipid-rich 
phenotype that are likely to progress and cause MACE within 5-year follow-up. We analysed data from 
two large-scale intravascular imaging studies and found that the cQFR software provides additional 
prognostic information and that together with the plaque characteristics derived by VH-IVUS enables 
more accurate detection of the lesions associated with MACE-R. 
Large scale prospective intravascular imaging studies of coronary atherosclerosis have demonstrated 
that an invasive assessment of plaque morphology allows detection of high-risk plaque features and 
identification of lesions that are likely to progress and cause events [9, 14–16]. However, in these 
studies the positive predictive value of the studied invasive imaging modalities in predicting MACE 
was low and therefore their routine use to stratify risk in the clinical setting is currently not 
recommended [17]. Combination of plaque morphology and physiology and in particular estimation of 
the endothelial shear stress (ESS) using computational fluid dynamic analysis of intravascular imaging 
data seems to provide additional prognostic information and detection of vulnerable plaques with a 
positive predictive value that exceeds >50% [11, 18]. However, ESS computation is a time consuming 
process that requires dedicated software and expertise facts that limit its broad use in the clinical 
practice. 
FFR was introduced to assess in real time the physiologic implications of coronary lesions and detect 
those that cause flow obstruction and ischemia. Reports have shown an inverse association between 
baseline FFR and the incidence of future events highlighting the prognostic value of this metric, even 
in non-flow limiting lesions [19, 20]. Studies also support a high agreement between FFR and QFR in 
patients with an acute coronary syndrome and underscore the value of QFR in detecting lesions that are 
likely to progress and cause events [21, 22]. The prognostic value of QFR/FFR is also supported by 
reports comparing their estimations with IVUS imaging variables showing a weak but statistical 
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significant correlation between MLA or PB and the FFR values. Moreover, the COMPETE-OCT sub-
study and a recent report that used multimodality intravascular imaging to assess plaque morphology 
demonstrated that significant stenoses are more likely to have a vulnerable phenotype [23, 24]. These 
findings indicate that there is an association between low FFR values and high-risk plaque features (i.e., 
MLA, PB and a vulnerable phenotype) that are predictors of future events. 
The present study examined for the first time the combined value of computationally-derived FFR and 
plaque morphology in predicting events. We analysed data from the PROSPECT and IBIS 4 studies 
and used an established software that is capable of retrospectively processing angiographic imaging 
data to derive FFR [7]. We found that QFR provided additional prognostic information to plaque 
morphology and enabled more accurate prediction of MACE. In particular 40.4% of the lesions with 
high risk plaque characteristics and low QFR values caused MACE while the event rate was lower in 
lesions with QFR≥0.96 or a non-high risk plaque morphology. These findings highlight the potential 
importance of the combined assessment of plaque morphology and physiology for more accurate 
characterisation of plaque vulnerability. Future prospective studies or retrospective analyses of 
currently ongoing intravascular imaging studies of atherosclerosis should be performed to validate the 
findings from the present report. Such studies may provide insight about the predictive efficacy of this 
approach in detecting vulnerable plaques and high-risk patients who might benefit from an aggressive 
treatment of atherosclerosis [25, 26].  
Advances in image processing and computational methods are anticipated to facilitate research towards 
this direction. Several solutions have been proposed in the literature for intravascular imaging analysis 
and fast computation of the pressure gradient across a lesion at rest or during hyperemia [27–29]. The 
OFR software is the first user-friendly tool that enables real-time segmentation of optical coherence 
tomography data and evaluation of lesion severity using computational modelling. Validation of this 
approach has shown a high agreement between OFR and FFR estimations [30, 31]. Similar software 
are expected to be designed in the future for the analysis of IVUS imaging data and used to predict more 





4.1. Study Limitations  
The key limitations of the present retrospective study is the fact that a large proportion of lesions were 
excluded from the analysis as accurate co-registration of IVUS and X-ray imaging was not possible or 
the DICOM information required to estimate QFR was not available in the angiograms acquired in the 
PROSPECT study. In addition, QFR analysis was performed in angiographic data that had already been 
acquired; a fact that may have affected the accuracy of QFR in assessing the hemodynamic severity of 
a lesion. Moreover, the number of events reported was small and thus in order to avoid model overfitting 
we included in the multivariate model only 2 non-colinear variables– presence of PB>70% and 
MLA<4mm2 and QFR – out of the 6 variables that were associated with MACE in the univariate 
analysis. Therefore, this analysis should be considered as an exploratory and hypothesis generating 
analysis requiring validation from larger studies. Moreover, VH-IVUS imaging was carried out using 
two different imaging systems (s5 in IBIS 4 and Invision Gold in PROSPECT); VH assessment from 
these two systems could give different estimations for plaque composition but we believe that it will 
have less effect in the estimation of plaque phenotype. In addition, the analysis of the VH-IVUS data 
was performed by two different core-labs that however are in close collaboration and use the same 
classification algorithm to define plaque phenotype [12]. Finally, the follow-up period (median 3.4 
years in PROSPECT and 5 years in IBIS 4) and the clinical end-points were different in the two studies 
as IBIS 4 study also reported revascularizations because of disease progression in coronary angiography 
and established evidence of ischemia at 13 months follow-up.  
4. Conclusions 
In the present post-hoc analysis assessment of plaque physiology using commercially available QFR 
software appear to provide additional prognostic information and more accurate identification of lesions 
that are likely to progress and cause MACE at 5-year follow-up compared with plaque morphology 
assessment derived from VH-IVUS alone. However, the small number of events reported do not allow 
us to draw firm conclusions; therefore, further confirmatory research is needed in a larger number of 
patients to quantify the predictive accuracy of combined QFR and intravascular imaging for the 
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Figure legends  
 
Figure 1. Flowchart of study design. 
 
Supplementary 2. Case examples that underscore the additional value of QFR in predicting lesions 
associated with MACE-R. Panel (A) shows the angiographic projection of a lesion that progressed and 
required revascularization at 1-year follow-up. VH-IVUS assessment of this lesion demonstrated a 
ThCFA phenotype with a MLA of 4.11mm2 and a PB of 71.7% (B). Panel C shows the QCA analysis 
of the segment assessed by VH-IVHS which indicates a minor stenosis (MLD: 2.0mm, DS: 42.0%), 
while panel (D) the estimated QFR values (fQFR: 0.94, cQFR: 0.94). Panel (E) portrays the 
angiographic projection of a lesion that remained quiescent. VH-IVUS examination demonstrated a 
TCFA phenotype with a MLA of 3.77mm2 and PB of 60.9% while in QCA analysis the estimated MLD 
and %DS were similar to the previous lesion (MLD: 2mm, %DS: 34.5). In this occasion however the 
QFR value was higher (fQFR: 0.98, cQFR: 0.97) than the lesion that progressed and require 
revascularisation. 
 
Figure 3. Kaplan-Meier curves showing the MACE-R rate in lesions classified according to VH-IVUS 
and QFR metrics. Lesions were classified in groups according to the presence of absence of (A) high-
risk plaque morphology (i.e., plaques with ≥2 high-risk features: defined as MLA<4mm2, PB>70% and 
a TCFA phenotype) and a low cQFR value (<0.97) and of (B) PB>70% and MLA<4mm2 and low 
cQFR. 
 
 
  
 
